X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25) 25
male (21) 21
adult (20) 20
hiv infections - drug therapy (18) 18
immunology (17) 17
infectious diseases (17) 17
middle aged (15) 15
virology (15) 15
female (14) 14
hiv infections - virology (12) 12
hiv (11) 11
hiv infections - immunology (11) 11
index medicus (10) 10
viral load (10) 10
anti-hiv agents - therapeutic use (8) 8
antiretroviral therapy (8) 8
cd4 lymphocyte count (8) 8
drug therapy (8) 8
drug therapy, combination (8) 8
efficacy (8) 8
treatment outcome (8) 8
hiv-1 - drug effects (7) 7
hiv-1 - genetics (7) 7
medicine, general & internal (7) 7
double-blind method (6) 6
hiv infection (6) 6
hiv infections - blood (6) 6
hiv-1 (6) 6
protease inhibitors (6) 6
ritonavir (6) 6
rna, viral - blood (6) 6
aged (5) 5
anti-hiv agents - adverse effects (5) 5
drug administration schedule (5) 5
hiv protease inhibitors - therapeutic use (5) 5
human immunodeficiency virus--hiv (5) 5
infection (5) 5
resistance (5) 5
ritonavir - therapeutic use (5) 5
safety (5) 5
abridged index medicus (4) 4
active antiretroviral therapy (4) 4
aids (4) 4
aids/hiv (4) 4
drug resistance (4) 4
health aspects (4) 4
hiv-1 - immunology (4) 4
hiv-infected patients (4) 4
immunodeficiency-virus type-1 (4) 4
lipodystrophy (4) 4
lopinavir (4) 4
reverse transcriptase inhibitors - adverse effects (4) 4
reverse transcriptase inhibitors - therapeutic use (4) 4
rna (4) 4
abacavir (3) 3
antiretroviral therapy, highly active (3) 3
article (3) 3
care and treatment (3) 3
clinical trials (3) 3
combination therapy (3) 3
darunavir (3) 3
dideoxynucleosides - therapeutic use (3) 3
follow-up studies (3) 3
hiv fusion inhibitors - adverse effects (3) 3
hiv fusion inhibitors - therapeutic use (3) 3
hiv-1 - isolation & purification (3) 3
hiv-associated lipodystrophy syndrome - chemically induced (3) 3
in-vivo (3) 3
pharmacology & pharmacy (3) 3
pyrimidinones - therapeutic use (3) 3
research (3) 3
reverse-transcriptase (3) 3
ritonavir - adverse effects (3) 3
therapy (3) 3
usage (3) 3
zidovudine - therapeutic use (3) 3
absorptiometry, photon (2) 2
adolescent (2) 2
anti-hiv agents - administration & dosage (2) 2
anti-retroviral agents - adverse effects (2) 2
anti-retroviral agents - therapeutic use (2) 2
antiretroviral drugs (2) 2
antiretroviral therapy, highly active - methods (2) 2
antiretrovirals (2) 2
antiviral agents (2) 2
base sequence (2) 2
body composition - drug effects (2) 2
bone-marrow (2) 2
ccr5 receptor antagonists (2) 2
cd8 (2) 2
cholesterol (2) 2
cohort (2) 2
coinfection (2) 2
cyclohexanes - adverse effects (2) 2
cyclohexanes - therapeutic use (2) 2
diarrhea (2) 2
double-blind (2) 2
drug resistance, viral (2) 2
drug-resistance (2) 2
evolution, molecular (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9712, pp. 396 - 407
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 2004, Volume 363, Issue 9407, pp. 429 - 438
Journal Article
Nature Medicine, ISSN 1078-8956, 03/2009, Volume 15, Issue 3, pp. 285 - 292
Journal Article
Journal Article
AIDS, ISSN 0269-9370, 08/2009, Volume 23, Issue 13, pp. 1679 - 1688
Objective: Present 96-week data from ongoing ARTEMIS (AntiRetroviral Therapy with TMC114 ExaMined In Naive Subjects) trial. Methods: Randomized, open-label,... 
Clinical trials | Darunavir | HIV | Protease inhibitors | Lopinavir | Antiretroviral therapy | INFECTIOUS DISEASES | EFFICACY | SAFETY | antiretroviral therapy | IMMUNOLOGY | ADHERENCE | HIV-INFECTED PATIENTS | DARUNAVIR-RITONAVIR | VIROLOGY | lopinavir | TREATMENT-EXPERIENCED PATIENTS | ACTIVE ANTIRETROVIRAL THERAPY | protease inhibitors | RESISTANCE | clinical trials | darunavir | 800/100 MG | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | Viral Load | HIV Infections - immunology | Ritonavir - adverse effects | HIV-1 - isolation & purification | Ritonavir - therapeutic use | Adult | Female | Antiretroviral Therapy, Highly Active - methods | HIV Protease Inhibitors - adverse effects | Drug Administration Schedule | Ritonavir - administration & dosage | HIV-1 - drug effects | HIV Infections - virology | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Treatment Outcome | CD4 Lymphocyte Count | HIV Protease Inhibitors - administration & dosage | Drug Resistance, Multiple, Viral | HIV Protease Inhibitors - therapeutic use | Sulfonamides - therapeutic use | Sulfonamides - adverse effects | HIV Infections - drug therapy | Pyrimidinones - administration & dosage | Sulfonamides - administration & dosage | Emtricitabine | RNA | Ritonavir | Exanthema | Diarrhea | Data processing | Lipids | Triglycerides | Statistics | Cholesterol | CD4 antigen | Index Medicus | AIDS/HIV
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2006, Volume 43, Issue 10, pp. 1337 - 1346
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2008, Volume 359, Issue 14, pp. 1429 - 1441
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2008, Volume 359, Issue 14, pp. 1442 - 1455
In key subgroups of the HIV-infected patients in the MOTIVATE 1 and MOTIVATE 2 studies, a consistent treatment benefit of maraviroc over placebo was seen at 48... 
CCR5 ANTAGONIST | MEDICINE, GENERAL & INTERNAL | EFFICACY | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | ACTIVE ANTIRETROVIRAL THERAPY | DRUG-RESISTANT HIV-1 | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | HEPATITIS-C | PROGNOSTIC VALUE | Triazoles - adverse effects | Humans | Middle Aged | Receptors, CCR5 - genetics | Male | RNA, Viral - blood | Hepatitis B - blood | Viral Load | Hepatitis B - complications | Cyclohexanes - therapeutic use | HIV Infections - immunology | Ethnic Groups | HIV Envelope Protein gp41 - therapeutic use | HIV-1 - chemistry | Hepatitis C - blood | Adult | Female | Hepatitis C - complications | Cyclohexanes - adverse effects | Drug Therapy, Combination | Odds Ratio | CCR5 Receptor Antagonists | Triazoles - therapeutic use | Anti-Retroviral Agents - therapeutic use | Double-Blind Method | HIV Infections - virology | Anti-Retroviral Agents - adverse effects | Genotype | Treatment Outcome | CD4 Lymphocyte Count | HIV Fusion Inhibitors - adverse effects | HIV-1 - genetics | HIV Fusion Inhibitors - therapeutic use | HIV Infections - drug therapy | Transaminases - blood | Aged | Peptide Fragments - therapeutic use | Antiviral agents | Care and treatment | Maraviroc | Comparative analysis | Health aspects | HIV infection | Drug therapy | Drug resistance | Human immunodeficiency virus--HIV | Chemokines | Index Medicus | Abridged Index Medicus
Journal Article